Indegene accelerated major drug launches for a mid-size pharma company collaborating to add an Fc-modified antibody to its oncology portfolio, targeting advanced treatments in the US and EU, while delivering a 28% boost in open rates, 30% reduction in unsubscribes, and 9% higher conversions. The company needed a new collaborative MarTech framework for effective, engaging communications and user experiences. Indegene's innovative software orchestrated seamless omnichannel campaigns, automated personalized content delivery, and optimized engagement metrics in real-time. This streamlined launches, enhanced audience resonance, and drove superior promotional outcomes across regions.

Join for free to read